XML 39 R23.htm IDEA: XBRL DOCUMENT

Subsequent Event	12 Months Ended
Subsequent Event	Oct. 31, 2016
Subsequent Events [Abstract]
Subsequent Event	Subsequent Event Subsequent to our fiscal year ended October 31, 2016, on November 6, 2016, CooperSurgical acquired Wallace, the in-vitro fertilization segment of Smiths Medical International, Ltd., a division of Smiths Group plc., for a purchase price of approximately $168.0 million, subject to customary closing adjustments.